Althiazide (BioDeep_00000175939)

   

human metabolite blood metabolite


代谢物信息卡片


6-Chloro-1,1-dioxo-3-(prop-2-enylsulphanylmethyl)-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulphonamide

化学式: C11H14ClN3O4S3 (382.98349540000004)
中文名称: 阿尔噻嗪
谱图信息: 最多检出来源 () 0%

分子结构信息

SMILES: C=CCSCC1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl
InChI: InChI=1S/C11H14ClN3O4S3/c1-2-3-20-6-11-14-8-4-7(12)9(21(13,16)17)5-10(8)22(18,19)15-11/h2,4-5,11,14-15H,1,3,6H2,(H2,13,16,17)

描述信息

C78275 - Agent Affecting Blood or Body Fluid > C448 - Diuretic > C49185 - Thiazide Diuretic

同义名列表

6 个代谢物同义名

6-Chloro-1,1-dioxo-3-(prop-2-enylsulphanylmethyl)-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulphonamide; 6-chloro-1,1-dioxo-3-[(prop-2-en-1-ylsulfanyl)methyl]-3,4-dihydro-2H-1λ⁶,2,4-benzothiadiazine-7-sulfonamide; 3-((Allylthio)methyl)-6-chloro-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide-1,1-dioxide; althiazide; Altozide; Altizide



数据库引用编号

10 个数据库交叉引用编号

分类词条

相关代谢途径

Reactome(0)

BioCyc(0)

PlantCyc(0)

代谢反应

0 个相关的代谢反应过程信息。

Reactome(0)

BioCyc(0)

WikiPathways(0)

Plant Reactome(0)

INOH(0)

PlantCyc(0)

COVID-19 Disease Map(0)

PathBank(0)

PharmGKB(0)

1 个相关的物种来源信息

在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有：

  • PubMed: 来源于PubMed文献库中的文献信息，我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表，这个列表按照代谢物同时出现的文献数量降序排序，取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
  • NCBI Taxonomy: 通过文献数据挖掘，得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序，取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
  • Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
  • Chemical Reaction: 在化学反应过程中，存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。

点击图上的相关代谢物的名称，可以跳转到相关代谢物的信息页面。



文献列表

  • Mark J Henderson, Kathleen A Trychta, Shyh-Ming Yang, Susanne Bäck, Adam Yasgar, Emily S Wires, Carina Danchik, Xiaokang Yan, Hideaki Yano, Lei Shi, Kuo-Jen Wu, Amy Q Wang, Dingyin Tao, Gergely Zahoránszky-Kőhalmi, Xin Hu, Xin Xu, David Maloney, Alexey V Zakharov, Ganesha Rai, Fumihiko Urano, Mikko Airavaara, Oksana Gavrilova, Ajit Jadhav, Yun Wang, Anton Simeonov, Brandon K Harvey. A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome. Cell reports. 2021 04; 35(4):109040. doi: 10.1016/j.celrep.2021.109040. [PMID: 33910017]
  • Tobie D Lee, Olivia W Lee, Kyle R Brimacombe, Lu Chen, Rajarshi Guha, Sabrina Lusvarghi, Bethilehem G Tebase, Carleen Klumpp-Thomas, Robert W Robey, Suresh V Ambudkar, Min Shen, Michael M Gottesman, Matthew D Hall. A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein. Molecular pharmacology. 2019 11; 96(5):629-640. doi: 10.1124/mol.119.115964. [PMID: 31515284]
  • R J B Peters, J E Oosterink, A A M Stolker, C Georgakopoulos, M W F Nielen. Generic sample preparation combined with high-resolution liquid chromatography-time-of-flight mass spectrometry for unification of urine screening in doping-control laboratories. Analytical and bioanalytical chemistry. 2010 Apr; 396(7):2583-98. doi: 10.1007/s00216-010-3484-3. [PMID: 20155493]
  • K Deventer, O J Pozo, P Van Eenoo, F T Delbeke. Detection of urinary markers for thiazide diuretics after oral administration of hydrochlorothiazide and altizide-relevance to doping control analysis. Journal of chromatography. A. 2009 Mar; 1216(12):2466-73. doi: 10.1016/j.chroma.2009.01.032. [PMID: 19187939]
  • K Deventer, G Baele, P Van Eenoo, O J Pozo, F T Delbeke. Stability of selected chlorinated thiazide diuretics. Journal of pharmaceutical and biomedical analysis. 2009 Feb; 49(2):519-24. doi: 10.1016/j.jpba.2008.11.001. [PMID: 19108977]
  • V Morra, P Davit, P Capra, M Vincenti, A Di Stilo, F Botrè. Fast gas chromatographic/mass spectrometric determination of diuretics and masking agents in human urine: Development and validation of a productive screening protocol for antidoping analysis. Journal of chromatography. A. 2006 Dec; 1135(2):219-29. doi: 10.1016/j.chroma.2006.09.034. [PMID: 17027009]
  • O L Charansonney, M Lièvre, M Laville, L Lion, E Derobert, N Visèle, S Decourt, M P de Rusunan, J Luciani, D Vasmant, J P Boissel, J P Grünfeld. The Eurevie Study: contrasting effect of piretanide and thiazides in mild to moderate hypertension. Therapie. 1997 May; 52(3):169-77. doi: NULL. [PMID: 9366100]
  • J L Doignon, J M Grognet, J J Thébault, M Caplain, M H Capron, B Pelletier, M Wehrlen, M Istin. [Pharmacokinetics in healthy subjects of althiazide and spironolactone in a fixed combination for 2 doses]. Therapie. 1990 Nov; 45(6):475-81. doi: NULL. [PMID: 2080486]
  • J P Grünfeld, M Wehrlen, B Pelletier, M H Capron. Spironolactone and altizide versus converting enzyme inhibitor (enalapril). The American journal of cardiology. 1990 Jun; 65(23):28K-32K. doi: 10.1016/0002-9149(90)91274-a. [PMID: 2191586]
  • P L Caraman, J L Fabre, F Maurice, P Netter, P Trechot. [Hypercalcemia from altizide. Apropos of a case in a patient with extramembranous glomerulonephritis and renal failure]. Therapie. 1983 Sep; 38(5):563-4. doi: NULL. [PMID: 6670082]
  • H Y Meltzer, R Belmaker, R J Wyatt, W Pollin, S Cohen. Serum creatine phosphokinase (CPK) activity in monozygotic twins discordant for schizophrenia: heritability of serum CPK activity. Comprehensive psychiatry. 1976 May; 17(3):469-75. doi: 10.1016/0010-440x(76)90051-1. [PMID: 6211]